MSMareike Schell

Mareike Schell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mareike Schell has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • André Kleinridders

    Department of Molecular and Experimental Nutritional Medicine, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany

    2 shared publications
  • Michaela Rath

    Cellular Physiology of Nutrition, Institute of Nutritional Science, University of Potsdam

    2 shared publications
  • Robert Hauffe

    Institute of Nutritional Science, Department of Molecular and Experimental Nutritional Medicine, University of Potsdam, Nuthetal, Germany

    2 shared publications
  • Annette Schürmann

    German Center for Diabetes Research (DZD), D-85764 München-Neuherberg, Germany; German Institute of Human Nutrition, Research Group Experimental Diabetology, D-14558 Nuthetal, Germany

    1 shared publication
  • Christiane Ott

    Department of Molecular Toxicology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany

    1 shared publication
  • Kai Kappert

    Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry , Charité – Universitätsmedizin Berlin , Berlin , Germany

    1 shared publication

Latest Publications

  • DEP-1 a Novel Modulator of Energy Metabolism

    by Simran Chopra, Robert Hauffe, Michaela Rath, Mareike Schell, André Kleinridders

    Obesity is associated with insulin and leptin resistance, which affects peripheral tissues as well as the brain. The novel density-enhanced phosphatase-1 (DEP-1), is a known negative modulator of insulin and leptin signaling. Intriguingly, diet-induced obese mice have increased DEP-1 expression in metabolic sensitive tissues, including the brain. In this study, the regulation of DEP-1-dependent metabolic effects was investigated in vitro and in vivo. To study the functional consequences of DEP-1 deficiency in vitro, we established a DEP-1 knockout (DEP-1 KO) in mouse undifferentiated dopaminergic-like Neuro-2a cells using CRISPR/Cas9. Additionally, we investigated the metabolic consequences of DEP-1 deficiency in the brain by crossing Dep-1 lox/lox mice to forebrain hippocampus-specific CamKIIa Cre mice and fed them a normal chow diet (NCD). DEP-1 KO cells portrayed a significant increase in phospho-ERK signaling upon acute insulin challenge shown by western blot analysis, suggestive of enhanced insulin signalling. Moreover, female DEP-1 KO mice fed a NCD revealed an increase in white-adipose tissue weight along with elevated adipogenic gene markers. On the other hand, male DEP-1 KO mice displayed significant upregulation in brown adipose tissue (BAT) gene markers in addition to an increase in protein expression of the different oxidative phosphorylation complexes subunits, indicating increased oxidative phosphorylation capacity in BAT of male DEP-1 KO mice [1] [2] [3] [4] [5]. This suggests that while in vitro DEP-1 deficiency subtly improves insulin sensitivity, DEP-1 KO mice demonstrate DEP-1 as a potential neuronal modulator of energy metabolism. Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue

    by Robert Hauffe, Michaela Rath, Mareike Schell, Katrin Ritter, Kai Kappert, Stefanie Deubel, Christiane Ott, Markus Jähnert, Wenke Jonas, Annette Schürmann, et al.